Should fibrinogen be replaced in a patient who is not actively bleeding?

Fibrinogen Replacement in Non-Bleeding Patients

Fibrinogen should NOT be replaced prophylactically in patients who are not actively bleeding, even if fibrinogen levels are low. The most recent high-quality guidelines explicitly state there is no good evidence to support prophylactic correction of abnormal coagulation tests in hemodynamically stable patients without active bleeding 1.

Clear Indications for Fibrinogen Replacement

Based on the 2025 Association of Anaesthetists guidelines, fibrinogen replacement (via cryoprecipitate or fibrinogen concentrate) is indicated ONLY in these specific scenarios 1:

Active Bleeding Context:

• Clinically significant bleeding AND fibrinogen level <1.5 g/L (<2 g/L in obstetric hemorrhage)
• Major hemorrhage where balanced transfusion protocols are being used

Pre-Procedure Context (NOT prophylactic):

• Fibrinogen level <1.0 g/L AND significant bleeding risk prior to a high-risk procedure, considering:
  • Personal/family bleeding history
  • Drug history (anticoagulants/antiplatelets)
  • Bleeding risk of the planned procedure

Special Circumstances:

• Bleeding associated with thrombolytic therapy
• Inherited hypofibrinogenemia (congenital disorders)

Why Not Replace Prophylactically?

The evidence is clear on this point. Seven randomized double-blind studies demonstrated that fibrinogen concentrates failed to reduce bleeding or transfusion needs when given prophylactically in cardiac surgery, urologic surgery, obstetric procedures, liver transplantation, and trauma 2. The 2018 ISTH guidance emphasizes that prophylactic administration before any hemorrhage is one of the key reasons fibrinogen replacement alone is unlikely to benefit patients.

Abnormal coagulation tests (PT, APTT) are poor predictors of bleeding in critically ill, hemodynamically stable patients and do not reflect true hemostatic status, particularly in advanced liver disease 1. This is a critical pitfall—many clinicians still attempt to "correct the numbers" without clinical bleeding, which is not evidence-based practice.

The Exception: High Bleeding Risk Procedures

The only scenario approaching prophylaxis is when fibrinogen is <1.0 g/L and you're about to perform a high-risk procedure. Even then, this requires careful consideration of the individual bleeding risk factors listed above 1. This is NOT blanket prophylaxis—it's risk-stratified intervention.

Common Pitfalls to Avoid

1. Do not transfuse based solely on laboratory values in stable, non-bleeding patients
2. Do not use FFP prophylactically to correct coagulation tests before low-risk procedures 1
3. Do not assume low fibrinogen equals bleeding risk without clinical context
4. Recognize that fibrinogen is the first factor to fall during major hemorrhage (<1.0 g/L), but this doesn't justify preemptive replacement 2

Practical Algorithm

Is the patient actively bleeding?

• YES → Check fibrinogen level

  • If <1.5 g/L (<2 g/L in obstetrics): Replace fibrinogen
  • If ≥1.5 g/L: Do not replace based on fibrinogen alone

• NO → Is a high-risk procedure planned?

  • YES → Check fibrinogen level
    • If <1.0 g/L AND significant bleeding risk factors present: Consider replacement
    • If ≥1.0 g/L: Do not replace
  • NO → Do not replace fibrinogen regardless of level

The evidence strongly supports a restrictive approach. Fibrinogen replacement is a therapeutic intervention for active bleeding or very high-risk scenarios, not a prophylactic measure to normalize laboratory values.